Sano Genetics | Latest News & Updates - Nov 20, 2024 Release

Sano Genetics is partnering with Glanzmann's Research Foundation and Hemab Therapeutics to conduct a survey on the daily life impacts of Glanzmann Thrombasthenia...


Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡


Sano Genetics

🌎 sanogenetics.com

Sano Genetics is a biotechnology research company based in Cambridge, England, focused on accelerating the transition to precision medicine. The company offers an end-to-end precision medicine platform that integrates genetic testing, recruitment, and long-term patient engagement, streamlining clinical operations and enhancing the efficiency of clinical trials.


Sano Genetics - Latest News and Updates

  • Sano Genetics is partnering with Glanzmann's Research Foundation and Hemab Therapeutics to conduct a survey on the daily life impacts of Glanzmann Thrombasthenia.
  • Sano Genetics partners with Neuron23 to streamline patient referrals and provide genetic testing and counseling for the NEULARK clinical trial in early Parkinson's disease.
  • Sandra Bläser has left Sano Genetics, where she served as VP Customer Success & Delivery, Patient Recruitment & Engagement in Ireland, to join Causaly as Principal - Strategic Engagement EMEA.

Sign up to receive regular updates


If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.